Vanguard Group
ADMS

Vanguard Group’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,765,031
Closed -$8.67M 4699
2021
Q3
$8.67M Buy
1,765,031
+13,211
+0.8% +$64.9K ﹤0.01% 3333
2021
Q2
$9.25M Buy
1,751,820
+34,336
+2% +$181K ﹤0.01% 3248
2021
Q1
$8.24M Buy
1,717,484
+743,872
+76% +$3.57M ﹤0.01% 3257
2020
Q4
$4.22M Buy
973,612
+42,470
+5% +$184K ﹤0.01% 3435
2020
Q3
$3.84M Hold
931,142
﹤0.01% 3281
2020
Q2
$2.38M Sell
931,142
-48,286
-5% -$124K ﹤0.01% 3383
2020
Q1
$2.83M Buy
979,428
+38,599
+4% +$112K ﹤0.01% 3199
2019
Q4
$3.57M Sell
940,829
-25,895
-3% -$98.1K ﹤0.01% 3280
2019
Q3
$4.95M Sell
966,724
-64,240
-6% -$329K ﹤0.01% 3141
2019
Q2
$6.39M Sell
1,030,964
-248,047
-19% -$1.54M ﹤0.01% 3080
2019
Q1
$9.09M Buy
1,279,011
+245,474
+24% +$1.75M ﹤0.01% 2877
2018
Q4
$8.83M Buy
1,033,537
+25,089
+2% +$214K ﹤0.01% 2824
2018
Q3
$20.2M Buy
1,008,448
+18,879
+2% +$378K ﹤0.01% 2574
2018
Q2
$25.6M Buy
989,569
+53,064
+6% +$1.37M ﹤0.01% 2459
2018
Q1
$22.4M Buy
936,505
+210,463
+29% +$5.03M ﹤0.01% 2454
2017
Q4
$24.6M Buy
726,042
+18,672
+3% +$633K ﹤0.01% 2407
2017
Q3
$15M Sell
707,370
-37,867
-5% -$802K ﹤0.01% 2621
2017
Q2
$13M Buy
745,237
+28,818
+4% +$504K ﹤0.01% 2648
2017
Q1
$12.5M Buy
716,419
+66,825
+10% +$1.17M ﹤0.01% 2660
2016
Q4
$11M Buy
649,594
+25,756
+4% +$435K ﹤0.01% 2703
2016
Q3
$10.2M Buy
623,838
+5,056
+0.8% +$83K ﹤0.01% 2673
2016
Q2
$9.37M Buy
618,782
+120,912
+24% +$1.83M ﹤0.01% 2681
2016
Q1
$7.2M Buy
497,870
+193,176
+63% +$2.79M ﹤0.01% 2784
2015
Q4
$8.63M Buy
304,694
+92,151
+43% +$2.61M ﹤0.01% 2722
2015
Q3
$3.56M Buy
212,543
+45,801
+27% +$767K ﹤0.01% 3124
2015
Q2
$4.37M Buy
166,742
+17,581
+12% +$461K ﹤0.01% 3074
2015
Q1
$2.61M Buy
149,161
+49,884
+50% +$873K ﹤0.01% 3297
2014
Q4
$1.72M Buy
99,277
+60,857
+158% +$1.06M ﹤0.01% 3339
2014
Q3
$716K Buy
38,420
+21,996
+134% +$410K ﹤0.01% 3605
2014
Q2
$300K Buy
+16,424
New +$300K ﹤0.01% 3785